AVERT - /links/AVERT

Sorted by: Last Added Time | Last Commented
Europe’s eastern region sees 108% increase in HIV infections in just 10 years...
Submitted to Category: /contrib/hiv, /contrib/Europe/
A new report by the European Centres for Disease Control (ECDC) and World Health Organization (WHO) shows that prevention efforts are failing, particularly in Central and Eastern Europe, as the number of people living with HIV in Europe reaches over 2 million for the first time.
By AVERT on 2017-06-12 15:32 UTC
13% of people living with HIV in the UK remain undiagnosed despite high standards of care...
Submitted to Category: /contrib/hiv, /contrib/health/
The UK has exceeded UNAIDS Fast-Track targets of getting people on treatment and virally suppressed, but falls behind on reaching those who are undiagnosed.
By AVERT on 2017-06-12 15:31 UTC
Viral load suppression among young people and adolescents falling behind in Malawi, Zambia and Zimbabwe...
Submitted to Category: /contrib/hiv, /contrib/Africa/
A number of southern African countries are making good progress towards the 90-90-90 Fast-Track Targets, but efforts to reach younger populations need to be redoubled.
By AVERT on 2017-06-12 15:29 UTC
Discovery of chemical messages between viruses could provide new way to induce HIV latency...
Submitted to Category: /contrib/hiv, /contrib/health/
One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.
By AVERT on 2017-06-12 15:22 UTC
People living with HIV may be more at risk of diabetes...
Submitted to Category: /contrib/hiv, /contrib/diabetes
HIV as a risk factor for diabetes has long been controversial, but new evidence shows that people living with HIV have increased diabetes prevalence compared to the general population.
By AVERT on 2017-06-12 15:18 UTC
“Knocking out” genes in cells of people living with HIV could lead to new methods of treatment, say scientists...
Submitted to Category: /contrib/hiv, /contrib/health/
Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression although more research is required.
By AVERT on 2017-06-12 15:17 UTC
Lack of female head of household and distance to clinic linked to loss to follow-up in Malawi...
Submitted to Category: /contrib/hiv, /contrib/malawi
Identifying individuals at high risk of disengaging with HIV care remains an important strategy for realising the benefits of antiretroviral treatment for public health.
By AVERT on 2017-06-12 15:17 UTC
HIV self-testing a useful tool for pre-exposure prophylaxis (PrEP) delivery in Kenya...
Submitted to Category: /contrib/hiv, /contrib/Africa/Kenya/
Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.
By AVERT on 2017-06-12 15:16 UTC
Strong trial results and high resistance barrier for integrase inhibitor treatment put Gilead on path to new HIV drug...
Submitted to Category: /contrib/hiv, /contrib/health/
Drug trial results for new integrase inhibitor show promising viral suppression rates.
By AVERT on 2017-06-12 15:15 UTC
Gaps in the global HIV response leave people with disabilities at high risk of infection | AVERT...
Submitted to Category: /contrib/hiv, /contrib/health/
People with disabilities in developing countries are at high risk of HIV infection with HIV prevalence nearly double that than among those without disabilities.
By AVERT on 2017-06-12 15:14 UTC
A serious threat to progress: World Health Organization warns of sharp rise in rate of HIV and tuberculosis co-infections in Europe...
Submitted to Category: /contrib/hiv, /contrib/tuberculosis
Testing all patients is vital if the proportion of HIV co-infections is to fall in the European Union and European Economic Area, the World Health Organization has announced ahead of World TB Day 2017.
By AVERT on 2017-06-12 13:45 UTC
Nanomedicine could reduce dose and cost of treatment for people living with HIV, early trials show...
Submitted to Category: /contrib/hiv, /contrib/nanotechnology
Initial trials using nanotechnology have shown that people living with HIV could reduce the dose of their medication by up to two-thirds with no loss of effectiveness - which could improve adherence and reduce costs.
By AVERT on 2017-06-12 13:42 UTC
Online-to-Offline model highly effective in reaching at-risk groups with PrEP services in Thailand...
Submitted to Category: /contrib/hiv, /contrib/lgbtq
Digital intervention shows success linking hidden, at-risk men who have sex with men (MSM) and transgender women with HIV testing and PrEP services – and has the potential to be replicated elsewhere with high internet penetration.
By AVERT on 2017-06-12 13:40 UTC
Asia performs better than Africa in keeping people adhering to HIV treatment...
Submitted to Category: /contrib/hiv, /contrib/health_policy
Weaker health systems and psychosocial factors may explain the differences in adherence patterns between Asia and Africa, the world’s two most HIV-affected regions.
By AVERT on 2017-06-12 13:38 UTC
Women prefer sex with circumcised men and play key role influencing men's VMMC decision...
Submitted to Category: /contrib/hiv
Women’s views on voluntary male medical circumcision form an important part of the delivery and mass roll-out of this HIV prevention strategy.
By AVERT on 2017-06-12 13:36 UTC
Positivity linked to better health outcomes in people living with HIV...
Submitted to Category: /contrib/hiv, /contrib/mental_health
First known intervention to increase positive attitudes in people newly diagnosed with HIV found to have profound health benefits.
By AVERT on 2017-06-12 13:33 UTC
India to provide free treatment for all people living with HIV...
Submitted to Category: /contrib/hiv, /contrib/Asia/India/
India, the country with the third largest HIV epidemic, moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.
By AVERT on 2017-06-12 13:28 UTC
Doctors in the USA see few cases of risk compensation among PrEP users...
Submitted to Category: /contrib/hiv, /contrib/healthcare
Most healthcare providers cite worries over risk compensation after providing HIV prevention drug PrEP, but experiences among doctors who do prescribe PrEP are positive.
By AVERT on 2017-06-12 13:26 UTC
Kenya begins mass roll-out of HIV self-testing and PrEP...
Submitted to Category: /contrib/Africa/Kenya/, /contrib/hiv
Kenya embraces new HIV testing technologies to scale-up HIV prevention efforts in the country.
By AVERT on 2017-06-12 13:23 UTC
Drug use patterns in the USA point to more rapid injecting...
Submitted to Category: /contrib/drug_addiction, /contrib/hiv
As prescription opioid addiction continues to increase in the USA researchers predict a rising epidemic of injecting-related diseases such as HIV and hepatitis.
By AVERT on 2017-06-12 13:21 UTC

Page 5 of 6

  • Need an account?